Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
20.46
+0.11 (0.54%)
At close: Dec 4, 2025, 4:00 PM EST
20.43
-0.06 (-0.29%)
Pre-market: Dec 5, 2025, 7:07 AM EST

Simulations Plus Revenue

In the fiscal year ending August 31, 2025, Simulations Plus had annual revenue of $79.18M with 13.09% growth. Simulations Plus had revenue of $17.46M in the quarter ending August 31, 2025, a decrease of -6.45%.

Revenue (ttm)
$79.18M
Revenue Growth
+13.09%
P/S Ratio
5.20
Revenue / Employee
$371,732
Employees
213
Market Cap
412.16M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Aug 31, 202579.18M9.17M13.09%
Aug 31, 202470.01M10.44M17.52%
Aug 31, 202359.58M5.67M10.52%
Aug 31, 202253.91M7.44M16.01%
Aug 31, 202146.47M4.88M11.73%
Aug 31, 202041.59M7.62M22.43%
Aug 31, 201933.97M4.30M14.51%
Aug 31, 201829.67M5.53M22.90%
Aug 31, 201724.14M4.17M20.86%
Aug 31, 201619.97M1.66M9.05%
Aug 31, 201518.31M6.85M59.80%
Aug 31, 201411.46M1.39M13.80%
Aug 31, 201310.07M622.16K6.58%
Aug 31, 20129.45M709.87K8.12%
Aug 31, 20118.74M-1.97M-18.42%
Aug 31, 201010.71M1.57M17.16%
Aug 31, 20099.14M175.30K1.95%
Aug 31, 20088.97M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings